Protocol for a modelling study to assess the clinical and cost-effectiveness of indefinite anticoagulant therapy for first unprovoked venous thromboembolism

INTRODUCTION: Deciding whether to stop or extend anticoagulant therapy indefinitely after completing at least 3 months of initial treatment for a first unprovoked venous thromboembolism (VTE) remains a challenge for clinicians, patients and policy makers. Guidelines suggest an indefinite duration of...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Faizan, Thavorn, Kednapa, Coyle, Doug, van Katwyk, Sasha, Tritschler, Tobias, Hutton, Brian, Le Gal, Gregoire, Rodger, Marc, Fergusson, Dean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Haematology (Incl Blood Transfusion)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827190/
https://www.ncbi.nlm.nih.gov/pubmed/36609323
http://dx.doi.org/10.1136/bmjopen-2021-053927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827190/
https://www.ncbi.nlm.nih.gov/pubmed/36609323
http://dx.doi.org/10.1136/bmjopen-2021-053927

Ejemplares similares